HomeNewsTrendsHealthCoronavirus crisis | BMC preparing for worst case scenario of 75,000 COVID-19 cases in Mumbai by May-end: Report

Coronavirus crisis | BMC preparing for worst case scenario of 75,000 COVID-19 cases in Mumbai by May-end: Report

With the projection of 75,000 COVID-19 cases in Mumbai by May-end, BMC is scrambling to convert schools, hotels, sports complexes and marriage halls into isolation facilities.

May 05, 2020 / 12:45 IST
Story continues below Advertisement
Representative image
Representative image

The Brihanmumbai Municipal Corporation (BMC) is working with the projection of India’s financial hub Mumbai, having 75,000 cases by the end of May, reports suggest.

According to a report by the Hindustan Times, of these 75,000 cases, 12,000 are projected to be symptomatic and the remaining 63,000 to be asymptomatic.

Story continues below Advertisement

The report suggests that 13,500 hospital beds have been identified for the symptomatic cases in the tertiary and peripheral hospitals. Besides this, about 80,000 beds have been identified for asymptomatic cases in schools, hostels, hotels, sports complexes and marriage halls.

The 75,000 cases number, however, is the “worst-case scenario” a BMC official said as per the report.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show